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Résumé en
anglais
Cystic fibrosis (CF) is a recessively inherited disease caused by genetic lesions in CF
transmembrane conductance regulator (CFTR) gene. CF is characterized by
exaggerated inflammation, progressive tissue damage, and chronic bacterial
colonization, mainly in the respiratory tract. The mechanisms underlying these
pathological changes are increasingly well understood. However, apoptotic
dysfunction in CF disease is still debated since studies report controversial results.
Nonetheless, it is clear that apoptosis participates to onset of pathology and
concerns various types of cells with variable susceptibility. Apoptosis is a
physiological process necessary for the preservation of homeostasis of epithelial
organization and function for clearance of inflammatory cells. Increased
susceptibility to apoptosis in epithelial cells and failed apoptosis in neutrophils
would contribute to the self-perpetuating inflammatory cycle in CF. Also, retention
of mutated CFTR in the endoplasmic reticulum participates to inflammation which
may trigger apoptosis. Independently of the sensibility to apoptosis of CF cells, it
has been shown that clearance of apoptotic cells, due in part to decrease in
efferocytosis, is flawed and that accumulation of such cells may contribute to
ongoing inflammation in CF patients. Despite great advance in understanding CF
pathophysiology, there is still no cure for the disease. The most recent therapeutic
strategies are directed to target CFTR protein using cell and gene therapy as well
as pharmacotherapy.
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